NCT02554396View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Presbyopia
Interventions
DRUG

PRX-100

ophthalmic solution

DRUG

Placebo

saline ophthalmic solution

Trial Locations (1)

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

LENZ Therapeutics, Inc

OTHER

NCT02554396 - Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia | Biotech Hunter | Biotech Hunter